Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials
Antimicrob Agents Chemother. 2015 Feb; 59(2):1119-26